Most Read articles

    Published in last 1 year |  In last 2 years |  In last 3 years |  All

    All
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Interpretation of Report on Cardiovascular Health and Diseases in China 2023
    LIU Mingbo, HE Xinye, YANG Xiaohong, WANG Zengwu
    Chinese General Practice    2025, 28 (01): 20-38.   DOI: 10.12114/j.issn.1007-9572.2024.0293
    Abstract10061)   HTML249)    PDF(pc) (2424KB)(6424)       Save

    The prevalence of cardiovascular disease (CVD) in China is on the rise. It is estimated that there are 330 million people with CVD, including 13 million cases of stroke, 11.39 million cases of coronary heart disease (CHD), 8.9 million cases of heart failure (HF), 5 million cases of pulmonary heart disease, 4.87 million atrial fibrillation, 2.5 million cases of rheumatic heart disease, 2 million cases of congenital heart disease, 45.3 million cases of peripheral arterial disease (PAD), and 245 million cases of hypertension. In 2021, the total number of discharges of patients with cardiovascular and cerebrovascular diseases in China was 27 649 800, accounting for 15.36% of the total number of discharges (including all inpatient diseases) in the same period, including 14 872 300 CVDs, accounting for 8.26%, and 12 777 500 cerebrovascular diseases, accounting for 7.10%. The economic burden of CVD on residents and society still increases, and the inflection point of CVD prevention and treatment has not yet arrived.

    Table and Figures | Reference | Related Articles | Metrics
    Chinese Guideline for Lipid Management (Primary Care Version 2024)
    Joint Committee on the Chinese Guidelines for Lipid Management
    Chinese General Practice    2024, 27 (20): 2429-2436.   DOI: 10.12114/j.issn.1007-9572.2024.0005
    Abstract4330)   HTML170)    PDF(pc) (1385KB)(2230)       Save

    Low-density lipoprotein cholesterol (LDL-C) is a pathogenic risk factor for atherosclerotic cardiovascular disease (ASCVD). In recent decades, the prevalence of dyslipidemia in the Chinese population increases continuously, it is urgent to improve blood lipid management in China. It is particularly important to carry out standardized blood lipid management at primary healthcare institutions. The Chinese Guideline for Lipid Management (Primary Care Version 2024) concisely recommends that LDL-C should be the preferred intervention target in lipid management, and the target values of LDL-C should be determined based on ASCVD risk stratification. The present guideline recommends to use moderate-intensity statins at the beginning of treatment on the basis of lifestyle intervention. If the LDL-C target level can not be reached, other lipid-lowering drugs like cholesterol absorption inhibitors or (and) proprotein convertase subtilisin/kexin type 9 inhibitors should be jointly used for the purpose of reaching the target value. The present guideline also provides blood lipid management strategies for special populations. We aim to provide guidance for primary healthcare professionals to carry out blood lipid management, and comprehensively improve their ability on blood lipid management, and thereby improve the primary and secondary prevention of ASCVD in China.

    Table and Figures | Reference | Related Articles | Metrics
    Guideline for Eexercise Therapy of Type 2 Diabetes Mellitus in China (2024 Edition)
    National Center of Gerontology, Chinese Diabetes Society, China Sport Science Society
    Chinese General Practice    2024, 27 (30): 3709-3738.   DOI: 10.12114/j.issn.1007-9572.2024.A0019
    Abstract4263)   HTML221)    PDF(pc) (1500KB)(6816)       Save
    Table and Figures | Reference | Related Articles | Metrics
    Chinese Expert Consensus on Grassroots Prevention and Treatment of Hypertension Combined with Type 2 Diabetes Mellitus and Dyslipidemia in Adults 2024
    Beijing Hypertension Association, China Association of Gerontology and Geriatrics, Beijing Community Health Service Association, Beijing Community Health Promotion Association
    Chinese General Practice    2024, 27 (28): 3453-3475.   DOI: 10.12114/j.issn.1007-9572.2024.0116
    Abstract3570)   HTML78)    PDF(pc) (2637KB)(3169)       Save

    Hypertension, type 2 diabetes mellitus (T2DM), and dyslipidemia are collectively referred to as the "three highs", which often coexist in the same individual. It significantly increases the risk of hospitalization, death, and relevant burdens for affected people. It is necessary to jointly control the risk and standardize the treatment of hypertension, T2DM and dyslipidemia. Primary healthcare institutions have become the main battlefield for the prevention and treatment of chronic diseases. Existing clinical evidence provides important insights into the prevention, treatment, and management of the "three highs", although norms, consensus, and guidelines for the co-management of the "three highs" in primary healthcare institutions at domestic and foreign are current not available. Four academic organizations led by Beijing Hypertension Association organized primary healthcare workers and invited experts and scholars from medical fields of cardiovascular diseases, endocrine, pharmacy, and public health services to participate in the consensus. Through widely soliciting clinical practice needs of primary healthcare workers, integrating and evaluating the evidence related to the prevention and treatment of the "three highs" in primary healthcare institutions, the consensus for primary healthcare in the prevention and treatment of the "three highs" including 21 opinions was developed after multiple rounds of discussions, revisions, and voting. The recommended opinions of this consensus aim to improve the awareness and ability of primary healthcare workers in the prevention and treatment of the "three highs", provide scientific strategic support, implement management with primary healthcare characteristics, and lay a solid foundation for comorbidity co-management.

    Table and Figures | Reference | Related Articles | Metrics
    Expert Consensus on Screening and Prevention of Diabetic Microvascular Disease for Primary Care (2024)
    Diabetes and Microcirculation Professional Committee of Chinese Society of Microcirculation, Primary Endocrine and Metabolic Diseases Group of the Chinese Society of Endocrinology
    Chinese General Practice    2024, 27 (32): 3969-3986.   DOI: 10.12114/j.issn.1007-9572.2024.0163
    Abstract3216)   HTML60)    PDF(pc) (846KB)(1165)       Save

    Diabetic microvascular disease (DMiVD) is the most common chronic complication of diabetes mellitus, and early identification and effective intervention can significantly improve patients' quality of life and prognosis. The Diabetes and Microcirculation Professional Committee of Chinese Society of Microcirculation and the Primary Endocrine and Metabolic Diseases Group of the Chinese Society of Endocrinology have convened experts in the field to revise the Expert Consensus on Screening and Prevention of Diabetic Microvascular Diseases for Primary Care (2024), based on the 2021 edition, considering the latest research advances and the specific needs of primary care. This consensus elaborates the screening methods, comprehensive management and prevention strategies for DMiVD (diabetic retinopathy, diabetic kidney disease, distal symmetric polyneuropathy and diabetic cardiomyopathy), clarifies the graded diagnosis and treatment and referral processes, emphasizes the importance of preventing and treating DMiVD, and offers guidance and recommendations for physicians, particularly primary care physicians and general practitioners. The aim is to reduce the incidence, progression, and disability associated with DMiVD, ultimately lowering morbidity and mortality rates.

    Table and Figures | Reference | Related Articles | Metrics
    Trend Analysis and Forecasting Study on the Changing Disease Burden of Rheumatoid Arthritis in China, 1990-2021
    LING Yao, ZHANG Wenbin, WANG Shihong, CHEN Yongze, DONG Wenjiao, DENG Xingyu, DING Yuanlin
    Chinese General Practice    2025, 28 (15): 1914-1922.   DOI: 10.12114/j.issn.1007-9572.2024.0284
    Abstract2927)   HTML13)    PDF(pc) (2415KB)(488)       Save
    Background

    Rheumatoid arthritis (RA) is a common chronic autoimmune disease, the treatment and care of which requires long-term investment, including drug therapy, surgical treatment and rehabilitation, etc., which imposes heavy economic and social burdens on the patient's family and the society, and an analysis of the trend of change in the burden of disease and the prediction of the burden of disease can provide references for the formulation of relevant prevention and treatment strategies.

    Objective

    To understand the changes in the burden of disease of RA in China from 1990 to 2021 and to predict the incidence, prevalence, and disability adjusted life years (DALYs) rates of RA in China from 2022 to 2042.

    Methods

    Burden of disease indicators such as DALYs, incidence and prevalence of RA from the Global Burden of Disease Study 2021 (GBD 2021) were extracted for the years 1990-2021, and the rate of change and estimated annual percentage change (EAPC) were calculated using SPSS 27.0, respectively. The autoregressive sliding average model (ARIMA) was used to project the incidence, prevalence and DALYs rates for 2022-2042.

    Results

    In 2021, the incidence, prevalence and DALYs rate of RA in China were 17.38/100 000, 334.25/100 000 and 58.61/100 000, respectively, which were 59.89%, 92.61% and 71.07% higher than those in 1990, and the incidence, prevalence and DALYs rate of RA in China showed an increasing trend between 1990-2021, with an EAPC 1.61%, 2.33% and 2.02%, respectively (P<0.05). The rates of incidence, prevalence, and DALYs in women were 22.55/100 000, 460.19/100 000, and 78.25/100 000, which in men were 12.45/100 000, 214.09/100 000, and 39.87/100 000 in 2021. In 2021, China's RA incidence reached its highest in the age group of 75-79 years (34.37/100 000), the prevalence in the 80 years old and above reached the highest (836.13/100 000), and the rate of DALYs was highest in the age group of 80 years old and above (223.81/100 000). The results of the ARIMA model showed that the incidence rate of RA in China was projected to be 20.26/100 000, the prevalence rate to be 468.60/100 000, and the rate of DALYs to be 82.09/100 000 in 2042, in which the incidence rate had increased by 15.57%, the prevalence rate and the rate of DALYs had increased by 37.94% and 37.90% respectively from the 2022 level, and there were significant age differences.

    Conclusion

    There is a clear trend of increasing disease burden of RA in China from 1990 to 2021, with age and gender differences. Incidence, prevalence and DALYs due to RA are expected to continue to rise by 2042. This suggests that the RA in China should implement appropriate primary and secondary prevention measures for key populations such as the elderly and menopausal women.

    Table and Figures | Reference | Related Articles | Metrics
    Chinese Guideline for Diagnosis and Treatment of Co-morbid Insomnia and Obstructive Sleep Apnea (2024)
    Chinese Academy Society of Sleep Medicine, Chinese Medical Doctor Association, Sleep Medicine Group, China Neurologist Association
    Chinese General Practice    2025, 28 (11): 1289-1303.   DOI: 10.12114/j.issn.1007-9572.2024.0483
    Abstract2413)   HTML48)    PDF(pc) (1571KB)(1329)       Save

    When insomnia and obstructive sleep apnea (OSA) coexist, it is referred to as comorbid insomnia and obstructive sleep apnea (COMISA). The prevalence of COMISA in the general population ranges from 0.6% to 19.3%. It is primarily characterized by difficulty falling asleep, frequent nighttime awakenings, early morning awakening, poor sleep quality, snoring or apnea during sleep, unrefreshing or nonrestorative sleep, excessive daytime sleepiness, fatigue, attention impairment, memory impairment, emotional disorders, and impaired quality of life. COMISA can lead to adverse outcomes in multiple systems and increase all-cause mortality. Therefore, it is significant to establish a guidline for the diagnosis, differential diagnosis, and standardized treatment of COMISA. The guideline was organized by the Chinese Academy Society of Sleep Medicine, Chinese Medical Doctor Association and Sleep Medicine Group, China Neurologist Association. It was formed by reviewing domestic and international COMISA diagnosis and treatment practices, through literature evidence review, and after extensive discussion. The guideline summarized the epidemiology, etiology and risk factors, pathophysiological mechanisms, clinical manifestations, assessment methods, diagnosis, differential diagnosis, and treatment studies of COMISA, providing a basis for decision-making in the diagnosis and treatment of COMISA for clinician.

    Table and Figures | Reference | Related Articles | Metrics
    Interpretation of the 2023 ESPEN Guideline on Nutritional Support for Polymorbid Medical Inpatients
    WU Taiqin, GAN Xiuni, GAO Yan, ZHANG Huan, YANG Li
    Chinese General Practice    2024, 27 (21): 2557-2564.   DOI: 10.12114/j.issn.1007-9572.2023.0824
    Abstract2397)   HTML131)    PDF(pc) (1313KB)(1093)       Save
    Due to the accelerating trend of aging and transformation of residents' lifestyles and behaviors in China, multiple chronic conditions have become a major public health challenge. The phenomenon of comorbidities complicates patients' conditions and poor nutritional status, causing a heavy burden on patients' health and society. In 2018, the European Society for Clinical Nutrition and Metabolism (ESPEN) published the ESPEN Guidelines on Nutritional Support for Polymorbid internal medicine patients, which provides 22 recommendations and four statements on nutritional screening, assessment, requirements, monitoring and procedure of intervention for polymorbid medical inpatients. Based on continuously updated research evidence, the 2018 version of the guideline was updated by the ESPEN Guideline Working Group in June 2023, ESPEN Guideline on Nutritional Support for Polymorbid Medical Inpatients, to provide evidence-based recommendations on nutritional support for the polymorbid patient population hospitalized in medical wards. This article interprets and focuses 15 key points of the guideline, include nutritional screening and assessment, oral nutritional supplements, enteral nutrition and parenteral nutrition, estimation of energy requirements, protein targets, micronutrients supplementation, disease-specific nutritional supplementation, early nutritional support, post-discharge nutritional support, monitoring of physical functions, energy and protein requirements, organizational changes in nutritional support, impact of underlying diseases on nutritional support, drug-nutrient interactions and nutritional biomarkers. In order to provide guidance for nutritional management of polymorbid patients in China.
    Table and Figures | Reference | Related Articles | Metrics
    Sleep Quality and Anxiety and Depression in Patients with Chronic Obstructive Pulmonary Disease and Their Influencing Factors: a Multicenter Cross-sectional Study
    LI Xingyang, SUN Wanqi, YIN Mengjie, DOU Tingting, LYU Yili, XU Wei, ZHA Zhenqiu
    Chinese General Practice    2024, 27 (20): 2437-2444.   DOI: 10.12114/j.issn.1007-9572.2023.0794
    Abstract2075)   HTML89)    PDF(pc) (1453KB)(744)       Save
    Background

    Respiratory problems in chronic obstructive pulmonary disease (COPD) patients are prone to poor sleep quality, anxiety and depression, but they are often ignored by medical staff and patients themselves. Understanding the sleep quality, anxiety and depression symptoms of patients with COPD and their influencing factors can help to improve the quality of life of patients, however, there are few relevant studies.

    Objective

    To investigate the sleep quality, anxiety and depression of patients with COPD and explore the influencing factors.

    Methods

    Convenience sampling was used to recruit COPD patients who visited the Department Respiratory Diseases and Critical Care Medicine of seven hospitals in Anhui Province from August to November 2022. Demographic characteristics, dyspnea grade, airflow restriction severity, risk of malnutrition, physical activity level, vaccination, and acute exacerbations in the last 1 year were collected. The Pittsburgh Sleep Quality Index (PSQI) and the Hospital Anxiety and Depression Scale (HADS) were used to evaluate the sleep quality and anxiety and depression symptoms of COPD patients, and the influencing factors were analyzed by multivariate Logistic regression.

    Results

    A total of 248 patients with COPD were investigated, among which the incidence of poor sleep quality was 60.9% (151/248), only 8.9% (22/248) of the patients thought they had good sleep quality, and more than half of the patients actually had insufficient sleep time (54.4%) or low sleep efficiency (60.1%). 29.4% (73/248) of COPD patients had at least one of the symptoms of anxiety or depression, of which 35 had anxiety symptoms, 61 had depression symptoms, and 23 had both anxiety and depression symptoms. Multivariate Logistic regression analysis showed that older ages (OR=1.052, 95%CI=1.018-1.086) and risk of malnutrition (OR=3.393, 95%CI=1.855-6.206) were risk factors for poor sleep quality in COPD patients. Regular physical activity was a protective factor for poor sleep quality in COPD patients (OR=0.450, 95%CI=0.242-0.834) (P<0.05). Acute exacerbations ≥2 times (OR=2.220, 95%CI=1.093-4.510) and malnutrition risk (OR=1.961, 95%CI=1.044-3.683) were risk factors for anxiety and depression symptoms in COPD patients (P<0.04). In COPD patients, PSQI score was positively correlated with HADS-A (rs=0.413) and HADS-D score (rs=0.430), and there was a positive correlation between HADS-A score and HADS-D score (rs=0.719, P<0.05) .

    Conclusion

    The incidence of poor sleep quality, anxiety and depression symptoms was high in COPD patients, and age, malnutrition risk, regular physical activity and number of acute exacerbations in the past year are important influencing factors. Medical staff, family members and patients themselves should improve the awareness of sleep quality, anxiety and depression, and actively carry out screening and intervention work for key patients to improve the sleep quality and mental health of patients.

    Table and Figures | Reference | Related Articles | Metrics
    Chinese Diabetes Behavior and Lifestyle Intervention Guidelines (2024)
    Diabetes Prevention and Control Committee of Chinese Preventive Medicine Association
    Chinese General Practice    2025, 28 (07): 777-796.   DOI: 10.12114/j.issn.1007-9572.2024.0548
    Abstract2020)   HTML56)    PDF(pc) (1713KB)(2616)       Save

    Behavior and lifestyle interventions (BLIs) can reduce blood glucose and blood pressure, regulate blood lipids, control obesity, reduce cardiovas cular events and are a first-line treatment for chronic diseases such as diabetes mellitus. BLIs include helping patients maintain a healthy diet, adhere to physical exercise, maintain a normal weight, ensure good sleep, avoid smoking and alcohol abuse, make good psychological adjustments, establish good social support, as well as scientific self-monitoring of blood glucose and adherence to drug therapy. Except for the severe hyperglycemia and acute complications requiring medication, patients with newly diagnosed diabetes mellitus should first undergo BLIs. BLIs should follow the principles of effectiveness-centered, mutual trust establishment, problem-solving orientation, integration, and individulization. Common strategies for BLIs include applying behavior change theories, utilizing behavior change technologies, effectively emlpoying communication strategies, improving patient behavior skills, and implementing patient-centered self-management education and support (DSMES). The steps of BLIs include evaluating behavior, lifestyle and their influencing factors, setting behavioral goals, developing intervention plans, and conducting interventions and effectiveness evaluation. The evaluation measures for the effectiveness of BLIs include process indicators, clinical outcomes, socio-psychological and behavioral outcomes, patient reports, and health outcomes. Evaluation can be performed using a combination of qualitative and quantitative methods. Common evaluation tools include the SDSCA, PAM, and DMSES.

    Table and Figures | Reference | Related Articles | Metrics
    The Application of Large Language Models in Primary Healthcare Services and the Challenges
    YAN Wenxin, HU Jian, ZENG Huatang, LIU Min, LIANG Wannian
    Chinese General Practice    2025, 28 (01): 1-6.   DOI: 10.12114/j.issn.1007-9572.2024.0277
    Abstract1901)   HTML80)    PDF(pc) (1218KB)(3177)       Save

    The primary healthcare system is key to achieving a health equity. In China, great obstacles are challenged by imbalanced medical resources, shortage of primary healthcare providers, and the prevention and treatment of chronic diseases. Artificial intelligence large language models have demonstrated strong advantages in the medical system. This article deeply explored the application of large language models in the primary healthcare system and the challenges. The large language models are expected to assist the diagnosis and treatment of common diseases in grassroot medical institutions, promote intelligent health education and chronic disease management, underpin primary health services in the undeveloped and remote areas, stimulate the leapfrog development of general medicine, and accelerate the industrialization of large language models in general diagnosis and treatment and primary health services, thus providing important support for the construction of healthy China.

    Reference | Related Articles | Metrics
    A Multicenter Randomized Controlled Clinical Trial Study on the Effect of Piwei Peiyuan Decoction Combined with Acupuncture in the Treatment of Chronic Atrophic Gastritis with Intestinal Metaplasia
    WU Kairui, YE Yu, LI Jiaoyue, PEI Bei, LI Xuejun, CHENG Hongliang
    Chinese General Practice    2024, 27 (20): 2466-2475.   DOI: 10.12114/j.issn.1007-9572.2023.0823
    Abstract1815)   HTML119)    PDF(pc) (1797KB)(531)       Save
    Background

    Chronic atrophic gastritis (CAG) with intestinal metaplasia (IM) is an independent risk factor for gastric cancer. Long-term inflammation and oxidative stress response stimulate the physical and mental state of patients. Under the modern medical model, proton pump inhibitors and gastric mucosal protective agents are increasingly unable to meet the high drug resistance of patients. It is urgent to seek effective new Chinese medicine treatments and multiple methods to treat CAG and IM.

    Objective

    To evaluate the clinical efficacy and safety of modified Piwei Peiyuan Decoction combined with acupuncture in the treatment of CAG with IM.

    Methods

    From January 2022 to September 2023, 202 patients with CAG and IM diagnosed by gastroscopy and pathological examination in the Department of Spleen and Stomach, the Center for Preventive Treatment of Disease, the Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine and the Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine were selected. The patients were divided into control group (n=67), treatment group A (n=68) and treatment group B (n=67) by random number table method. All patients participated in 6 weeks of treatment: (1) Control group: aluminum magnesium suspension combined with folic acid tablets (3 times/d) ; (2) Treatment group A: to add and subtract syndrome types of Piwei Peiyuan Decoction (2 times/d) ; (3) Treatment group B: Piwei Peiyuan Decoction (the same as group A) combined with acupuncture (1 time/d), with Zusanli, Liangqiu, Gongsun, Neiguan, Zhongwan as the main points, according to the syndrome type selection of acupoints. Before and 6 weeks after treatment, OLGA, OLGIM staging, gastric mucosal pathological efficacy, gastric mucosal pathological score, clinical symptom score, PRO scale score, drug-related adverse events (AE) and adverse drug reactions (ADR) were recorded.

    Results

    A total of 192 patients completed the 6-week course of treatment (62 in the control group, 66 in the treatment group A, and 64 in the treatment group B). The effective rate of the control group was 48.39% (30/62), the effective rate of the treatment group A was 69.70% (46/66), and the effective rate of the treatment group B was 71.88% (46/64). There was a statistically significant difference in the effective rate among the three groups (χ2=9.144, P=0.01). After treatment, the gastric mucosal pathological score, clinical symptom score and PRO scale score in the three groups were lower than those in the same group before treatment (P<0.05). Pathological score of gastric mucosa: the scores of chronic inflammation, atrophy and IM in treatment group A and treatment group B were lower than those in control group, and the scores of active inflammation and dysplasia were higher than those in control group (P<0.05). Clinical symptom score: the scores of epigastric fullness and epigastric pain in treatment group A and treatment group B were lower than those in control group (P<0.05). The PRO scale score: the treatment group A and the treatment group B were lower than the control group in acid reflux, dyspepsia, defecation, psychological state, systemic symptoms and total score (P<0.05). There was no significant difference in the incidence of AE and ADR among the three groups (P>0.05) .

    Conclusion

    The overall clinical efficacy of Piwei Peiyuan Decoction combined with acupuncture is better than that of aluminum magnesium suspension combined with folic acid tablets, which is better than that of traditional antacids and gastric mucosal protective agents.

    Table and Figures | Reference | Related Articles | Metrics
    Current Status and Influencing Factors of Dysphagia among the Elderly in Communities: a Cross-sectional Study
    XU Su, CAI Wenwei, LI Chenyi, WANG Guanghui, XU Youduan
    Chinese General Practice    2024, 27 (17): 2083-2090.   DOI: 10.12114/j.issn.1007-9572.2023.0832
    Abstract1782)   HTML75)    PDF(pc) (1763KB)(581)       Save
    Background

    Dysphagia, a prevalent geriatric syndrome, has been witnessing an upward trend in incidence rates, potentially leading to severe complications like aspiration pneumonia and asphyxia. Despite its significance, research on the prevalence and determinants of dysphagia among community-dwelling elderly remains scarce.

    Objective

    This study aims to ascertain the prevalence of dysphagia among Shanghai's elderly community by identifying influencing factors and analyzing occurrence rates and determinants across different age brackets.

    Methods

    Employing a cross-sectional survey approach, the study was conducted from July 2022 to May 2023. Using convenience sampling, the study involved 358 individuals aged 60 and above, selected from the outpatient and home care services of five community health service centers in Huangpu, Baoshan and Fengxian Districts of Shanghai. Demographic data were collected, and measurements of the Appendicular Skeletal Muscle Index (ASMI), grip strength, and walking speed were taken. The Eating Assessment Tool-10 (EAT-10) was utilized to assess the risk of dysphagia among the elderly.

    Results

    Out of the 358 community-dwelling elderly individuals surveyed, 80 (22.3%) exhibited symptoms of dysphagia (EAT-10≥3) (dysphagia group). Multivariate Logistic regression analysis identified advanced age (≥80 years) (OR=18.484, 95%CI=3.571-95.679), depressive state (OR=4.135, 95%CI=1.280-13.364), and a history of choking (OR=13.650, 95%CI=4.345-42.877) as significant risk factors for dysphagia (P<0.05). Conversely, a high Barthel Index (OR=0.891, 95%CI=0.832-0.953) and a robust ASMI (OR=0.330, 95%CI=0.199-0.547) emerged as protective factors (P<0.05). When stratified by age, the prevalence rates of dysphagia were 5.0% (6/119), 11.1% (16/144), and 61.1% (58/95) for the age groups 60-69, 70-79, and ≥80 respectively, with statistically significant differences (P<0.05). Significant disparities were noted between dysphagia and non-dysphagia groups in terms of BMI, ASMI, and depression status for ages 60-69 (P<0.05), grip strength, calf circumference, depression, Barthel Index, and choking history for ages 70-79 (P<0.05), and ASMI, grip strength, walking speed, Barthel Index, MMSE scores, and choking history for ages ≥80 (P<0.05). Within the dysphagia cohort, ASMI and grip strength in the 70-79 and ≥80 age groups were lower compared to the 60-69 age group (P<0.05). The walking speed of individuals aged ≥70 was reduced relative to those aged 60-69 (P<0.05). Additionally, individuals aged ≥80 showed a higher choking incidence and scored lower on the Barthel Index and MMSE than those aged 60-79 (P<0.05) .

    Conclusion

    The prevalence of dysphagia among community-dwelling elderly in Shanghai is notably high and progressively increases with age, with a corresponding rise in influencing factors. It is imperative to intensify dysphagia screening, particularly among the elderly with depressive symptoms or a history of choking. Enhancing muscle mass and self-care capabilities, coupled with age-specific preventive measures, can substantially alleviate the disease burden and improve prognoses.

    Table and Figures | Reference | Related Articles | Metrics
    Efficacy and Preliminary Mechanism of Precise Exercise Prescriptions for Anxiety, Depression, and Cognitive Function in Patients with Stroke: a Randomized Controlled Trial
    QIAN Zhen, LU Tongbo, HE Jun, ZHU Haiying, WANG Jin, GONG Zunke
    Chinese General Practice    2024, 27 (20): 2445-2450.   DOI: 10.12114/j.issn.1007-9572.2023.0738
    Abstract1730)   HTML73)    PDF(pc) (1482KB)(396)       Save
    Background

    In the current rehabilitation environment, emotional issues and cognitive dysfunctions in stroke patients are often overshadowed by physical, speech, and swallowing difficulties, leading to their underestimation in clinical rehabilitation. This oversight can result in adverse outcomes, impacting the overall success of rehabilitation. Currently, clinical treatments primarily rely on pharmacotherapy to alleviate symptoms, which has limited effectiveness and can cause a range of adverse reactions.

    Objective

    To observe the efficacy of precision exercise prescriptions on anxiety, depression, and cognitive functions in stroke patients and to preliminarily analyze the underlying mechanisms of action.

    Methods

    A total of 84 stroke patients hospitalized in the Rehabilitation Department of Changzhou Dean Hospital from January 2022 to March 2023 were selected. They were randomly divided into a control group (42 patients) and an experimental group (42 patients). The control group received standard rehabilitation treatment, while the experimental group received precision exercise prescriptions based on cardiopulmonary exercise testing (CPET) results in addition to standard rehabilitation, over 12 weeks. The Self-rating Anxiety Scale (SAS), Self-rating Depression Scale (SDS), Mini-mental State Examination (MMSE) scores, and Homocysteine (Hcy) levels were compared before and after rehabilitation training in both groups. A Pearson correlation analysis was conducted between pre-rehabilitation Hcy levels and SAS, SDS, MMSE scores.

    Results

    All 42 patients in the experimental group completed the CPET and the 12-week precision exercise prescription rehabilitation without any adverse events. Before rehabilitation training, there were no statistically significant differences in SAS, SDS, MMSE scores, and Hcy levels between the two groups (P>0.05). After rehabilitation training, the scores of SAS, SDS, and Hcy levels in the experimental group were significantly lower compared to pre-treatment values (P<0.05), and which were significantly lower than those of the control group (P<0.05). The MMSE score in experimental groups increased significantly after interventions compared to pre-treatment value (P<0.05), and it was significantly higher than that of the control group (P<0.05). There were no significant differences in SAS, SDS, MMSE scores, and Hcy levels before and after rehabilitation training in the control group (P>0.05). Pearson correlation analysis revealed a positive correlation between Hcy levels and SAS, SDS scores (r-values of 0.420 and 0.507, respectively, P<0.05) and no correlation with MMSE scores (r=0.079, P=0.473) .

    Conclusion

    Our findings suggest that precision exercise prescriptions significantly improve anxiety, depression, and cognitive functions in stroke patients, suggesting their potential as a novel therapeutic approach in clinical applications. Hcy may be one of the mechanisms through which precision exercise prescriptions improve anxiety and depression in stroke patients. Further research is needed to determine whether Hcy is related to the improvement of cognitive functions through this prescription.

    Table and Figures | Reference | Related Articles | Metrics
    A Randomized Controlled Trial of Myofascial Release Therapy in Patients with Chronic Nonspecific Lower Back Pain
    RAN Qingzhi, LI Aoshuang, CHEN Hengwen, ZHANG Jianmei, HE Benxiang
    Chinese General Practice    2024, 27 (20): 2451-2457.   DOI: 10.12114/j.issn.1007-9572.2023.0681
    Abstract1547)   HTML75)    PDF(pc) (1516KB)(490)       Save
    Background

    Chronic non-specific low back pain (CNLBP) has become one of the common causes of limited activity, which seriously threatens the physical and mental health and quality of life of patients. According to certain studies, sensitivity and tension in the myofascial tissue play an important role in chronic pain disorders. By releasing fascial tension, myofascial release theropy (MFR) is primarily used to relieve pain; however, there is a lack of high-quality clinical evidence to support this application.

    Objective

    To investigates the effectiveness of MFR in CNLBP cases treated non-surgically.

    Methods

    From January to December 2022, 56 patients with CNLBP were recruited as study subjects by Chengdu Sports Institute Sports Hospital. The patients were then divided into two groups using a randomised number table. The MFR group received MFR intervention (lumbar-abdominal MFR intervention) and the patients in the control group (CG group) received pseudo-MFR intervention (pseudo-MFR intervention in the same area) for the duration of 4 weeks, once a week for 20 minutes each time. The following variables were measured: Visual Analogue Scale (VAS) scores, Activities of Daily Living (ADL) scores, Oswestry Dysfunction Index (ODI), lumbar joint mobility[including anterior lumbar flexion (ALF), posterior lumbar extension (LR) and lumbar spine rotation (LSR) on both sides], scores on the SAS, and changes in tumour necrosis factor α (TNF-α) .

    Results

    A total of 56 subjects were enrolled in this study. Of these, 8 cases were lost, 8 cases were automatically withdrawn and 40 cases -20 in the MFR group and 20 in the CG group eventually completed follow-up. There were no significant difference in VAS scores, ADL scores, ODI scores, ALF scores, SAS scores, SDS scores and TNF-α level between two groups before intervention (P>0.05). LR and LSR in MFR group were lower than those in CG group before intervention (P<0.05). After 4 weeks of intervention, VAS, ODI, SAS, SDS scores and TNF-α levels in MFR group were lower than those in CG group, ADL scores were higher than those in CG group, ALF, LR, LSR were higher than those in CG group (P<0.05). After 4 weeks of intervention, VAS, ODI, SAS, SDS scores and TNF-α levels in MFR group were lower than before intervention, ADL scores were higher than before intervention, ALF, LR, LSR were higher than before intervention (P<0.05) .

    Conclusion

    These results highlight the importance of MFR has been shown to have a better safety profile in patients with CNLBP, lowering the pain threshold, increasing lumbar joint mobility and improving negative psychological states such as anxiety and depression.

    Table and Figures | Reference | Related Articles | Metrics
    Psychology and Behavior Investigation of Chinese Residents: Concepts, Practices and Prospects
    WU Yibo, FAN Siyuan, LIU Diyue, SUN Xinying
    Chinese General Practice    2024, 27 (25): 3069-3075.   DOI: 10.12114/j.issn.1007-9572.2024.0075
    Abstract1435)   HTML32)    PDF(pc) (1375KB)(840)       Save

    To provide researchers with a comprehensive understanding of the Psychology and Behavior Investigation of Chinese Residents (PBICR), this paper introduces its background and features from four aspects. In terms of design concepts, PBICR focuses on many aspects of mental health and health behaviours in the Chinese population, takes full account of timeliness and efficiency, adheres to the original intention of data openness and data sharing, builds a high-quality database with a large-sample, multi-centre, repetitive, nationwide cross-sectional design, and promotes data mining and exchange and cooperation; in terms of survey implementation, PBICR adopts a combination of population size-proportional, multistage sampling and quota sampling, and obtains data through face-to-face field surveys with strict quality control to ensure the representativeness and reliability of the samples; in terms of output, PBICR's research content is rich and updated in line with international hotspots, which can satisfy the demand for research on diversified variables and data, and the results of its past research have a higher influence in many fields such as public health, management, communication, and psychology; Looking ahead, PBICR will gradually complete the construction of databases from the general database to sub-databases, pay attention to special populations and a wide range of regions around the world, add tracking surveys and biomedical data research perspectives, and have great research potential to drive research on the mental and behavioural health of Chinese residents through the overall layout of the multi-dimensional.

    Table and Figures | Reference | Related Articles | Metrics
    Development of a Short Version of the Health Literacy Scale Based on Classical Test Theory and Item Response Theory
    SUN Xiaonan, CHEN Ke, WU Yunchou, TANG Jingqi, WANG Fei, SUN Xinying, HE Miao, WU Yibo
    Chinese General Practice    2024, 27 (23): 2931-2940.   DOI: 10.12114/j.issn.1007-9572.2023.0072
    Abstract1416)   HTML33)    PDF(pc) (2499KB)(4429)       Save
    Background

    Health literacy is closely associated with health status, most domestic studies tend to use multidimensional and multi-item tools for assessing health literacy, lacking simple and effective assessment methods.

    Objective

    To simplify health literacy scale and conduct psychometric test within the Chinese population.

    Methods

    Adults aged 18 years and above were selected from the "China Family Health Index Survey (2021) " for this investigation. Based on inclusion and exclusion criteria, a total of 7 449 participants were selected and randomly divided into two sample sets, including 3 680 cases in sample set 1 and 3 769 cases in sample set 2. The general information questionnaire, Short-form Health Literacy Questionnaire (HLS-SF12), Perception Social Support Scale (PSSS), and Family Health Scale Short-form (FHS-SF) were administered to the respondents. Classical test theory (CTT) and the Mokken model in item response theory (IRT) were used to screen the original items, and validation analyses such as reliability and validity of the simplified scales were also conducted.

    Results

    A 9-item version (HLS-SF9) and a 4-item version (HLS-SF4) were simplified by using CTT and the Mokken model, respectively. Both the HLS-SF9 and the HLS-SF4 had no ceiling effect or floor effect, and the Cronbach's α coefficients for both were 0.913 and 0.842, with split-half reliabilities of 0.871 and 0.815, respectively. The exploratory factor analysis of HLS-SF4 revealed one common factor, accounting for 67.813% of the cumulative variance, with factor loadings exceeding 0.81 for each item. The confirmatory factor analysis of HLS-SF9 showed that χ2/df was 10.844, goodness of fit index (GFI) was 0.985, adjusted goodness of fit index (AGFI) was 0.971, normative fit index (NFI) was 0.986, comparative fit index (CFI) was 0.987, and root mean squared error of approximation (RMSEA) was 0.051. The correlation analysis demonstrated positive correlation of HLS-SF9 and HLS-SF4 with PSSS (r=0.367, 0.292, P<0.001), as well as FHS-SF (r=0.340, 0.237, P<0.001), respectively. The intraclass correlation coefficients (ICC) (95%CI) for the criterion validity of HLS-SF9 against HLS-SF12 was 0.989 (0.988-0.999), while for HLS-SF4 against HLS-SF12 was 0.892 (0.886-0.899) .

    Conclusion

    The simplified health literacy scales have good reliability and validity, which are reliable and effective tools for assessing the health literacy of the Chinese population. Researchers can choose the scale according to the needs of research precision (HLS-SF9) or assessment time (HLS-SF4) .

    Table and Figures | Reference | Related Articles | Metrics
    Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2025 Report
    CHEN Dian, LONG Huanyu, ZHANG Congxi, CHU Lanhe, LI Shurun, CHEN Yahong
    Chinese General Practice    2025, 28 (16): 1937-1949.   DOI: 10.12114/j.issn.1007-9572.2024.0588
    Abstract1376)   HTML17)    PDF(pc) (1793KB)(935)       Save

    The global initiative for chronic obstructive lung disease (GOLD) 2025 report, released on November 11th, 2024, marks the second update since GOLD 2023. Overall, this version maintains similar definition, diagnosis, assessment, and treatment for COPD as in GOLD 2024, but with revisions and expansions in 12 specific areas. These include: added explanations and references on lung function trajectories, expanded content on dysbiosis, updates and additions to spirometry, revised cardiovascular risk information for COPD patients, updated guidance on CT imaging for COPD, new insights into the impact of climate change on COPD, updated vaccination recommendations, updated follow-up pharmacological treatments, new guidance for delivery of pulmonary rehabilitation, revised recommendations on ICS withdrawal in patients on LABA+ICS therapy, updated information on PDE3 and PDE4 inhibitors and other exacerbation-reducing medications, and additional content on pulmonary hypertension. The article introduces and interprets the new contents.

    Table and Figures | Reference | Related Articles | Metrics
    Research on the Influencing Factors and Countermeasures of Fertility Willingness among Different Age Groups in China
    LIU Xinxin, SUI Jinhui, WU Bangdong, LIU Yan, LIANG Xiaohui, ZHAO Yang
    Chinese General Practice    2025, 28 (08): 973-979.   DOI: 10.12114/j.issn.1007-9572.2024.0139
    Abstract1343)   HTML17)    PDF(pc) (1777KB)(506)       Save
    Background

    The willingness of families to have children plays a crucial role in long-term population development. Currently, China is experiencing a significant risk of low fertility, with low fertility becoming the prevailing trend.

    Objective

    Under the macro background of the comprehensive liberalization of the ''three-child policy'', this study aims to analyze the willingness of the population to have children and the varying influencing factors across different age groups and establish a foundation for developing pertinent fertility policies by elucidating the concerns about fertility held by various age groups.

    Methods

    The data used in this study was sourced from the 2021 China Comprehensive Social Survey (CGSS). This study selected a population aged 20-44 years old, and after excluding missing variables, a total of 2 525 samples were included, including 1 444 females. A study on the entire population is conducted in order of age from young to old, with one group every 5 years old, for a total of 5 groups; Research on women was divided into two groups based on age groups of 34 and 35 and above. Using multiple variables from three dimensions of personal characteristics, family characteristics, and attitudes as possible influencing factors, an ordered Logistic regression model was used to analyze the factors affecting fertility intention in the entire population and only for women.

    Results

    The number of people willing to have two children accounted for 59% of the total survey population (1 491/2 525), and the group under 34 years old had a higher willingness to have zero children compared to the group over 35 years old (P<0.05). The results of Logistic regression analysis showed that, among individual characteristic variables, individuals with better health conditions were more likely to have a higher willingness to have children, which was significant in the population aged 35-39 and women over 35 years old (P<0.05). In the family characteristic variables, people with a larger family size were more likely to have a higher willingness to have children, which was significant in the population aged 25 and above and women over 35 years old (P<0.05). There was a higher likelihood of having a stable partner with a higher willingness to conceive, which was significant in women under 34 years old (P<0.05). In the concept attitude variables, all variables of the 20-24 were group were significant, and the results showed diversity in other age groups.

    Conclusion

    The current mainstream fertility intention is to have two children, and the fertility intention of young people (under 34 years old) is relatively high. Better physical health and larger family size are more prominent in the age group of 35 and above, and attitudes have a stronger impact on fertility intentions, with significant age differences. It is recommended to pay attention to the reproductive views of different age groups, strengthen family, social, and policy support, attach importance to women's physical health, and provide medical support for childbirth.

    Table and Figures | Reference | Related Articles | Metrics
    Association between Cumulative Episodes of C-reactive Protein Elevations and Somatic/Non-somatic Depressive Symptoms among Chinese Middle-aged and Older Adults: Prospective Cohort Study
    ZHAO Ningxuan, JIANG Lin, HU Meijing, YAO Qiang, MAO Yineng, ZHU Cairong
    Chinese General Practice    2024, 27 (17): 2070-2076.   DOI: 10.12114/j.issn.1007-9572.2023.0869
    Abstract1256)   HTML25)    PDF(pc) (1708KB)(322)       Save
    Background

    Whether considering the cumulative effect of sustained C-reactive protein (CRP) and distinguishing different aspects of depressive symptoms may be the reasons for the inconsistent conclusions of previous studies on the association between CRP and depressive symptoms among middle-aged and older adults. The relationship between cumulative effects of CRP elevations and different aspects of depressive symptoms in middle-aged and older adults in China is not well understood.

    Objective

    This study aims to examine the relationship between cumulative episodes of CRP elevations over two successive determinations and depressive symptoms, as well as somatic and non-somatic retardation, among Chinese middle-aged and older adults.

    Methods

    This study used public data from the 2011-2018 Chinese Health and Retirement Longitudinal Study (CHARLS) and included 3 868 subjects. They were categorized based on the frequency of CRP elevations over two consecutive measurements: "elevated on zero occasion" (n=2 918), "elevated on one occasion" (n=763), and "elevated on two occasions" (n=187). Depressive symptoms were assessed using the Center for Epidemiological Studies Depression Scale (CESD-10) in 2011, 2015, and 2018, capturing both somatic and non-somatic dimensions. Multiple linear was used to explore the associations between cumulative episodes of CRP elevations over two successive determinations with depressive symptom scores in 2018, as well as the scores of somatic and non-somatic components separately. Multivariate Logistic regression was used to investigate the effects of cumulative episodes of CRP elevations on the risk of depressive symptoms in 2018.

    Results

    The results of multiple linear regression analysis showed that after adjusting for all covariates, elevated on two occasions compared with elevated on zero occasion, which was an influential factor for the total score of depressive symptoms (β=1.22, P<0.05), the score of somatic depressive symptoms (β=0.51, P<0.05) and the score of non-somatic symptoms (β=0.71, P<0.05). Logistic regression analysis showed that after adjusting for all covariates, elevated on two occasions were associated with a higher risk of depressive symptoms than elevated on zero occasion (OR=1.64, 95%CI=1.18-2.29) .

    Conclusion

    Among Chinese middle-aged and older adults, there is a positive association between cumulative effects of CRP elevations and depressive symptoms, encompassing both somatic and non-somatic retardation. Addressing chronic inflammation and treating chronic inflammatory diseases promptly may help mitigate depression risk.

    Table and Figures | Reference | Related Articles | Metrics
    Risk Factors Analysis of Long-term Prognosis in Patients with D2 Radical Surgery for Stage Ⅲ Gastric Cancer after Adjuvant Chemoradiotherapy: Based on the Data of 10-year Follow-up
    MA Guifen, ZHANG Qian, LIU Juan, SUN Jing, LIN Genlai
    Chinese General Practice    2024, 27 (17): 2091-2097.   DOI: 10.12114/j.issn.1007-9572.2023.0673
    Abstract1223)   HTML21)    PDF(pc) (1878KB)(258)       Save
    Background

    Locally advanced gastric cancer mainly includes stage Ⅲ gastric cancer, which is mainly treated with comprehensive therapy. Postoperative recurrence is a key factor affecting the prognosis of patients.

    Objective

    To explore the influencing factors of long-term prognosis in patients with stage Ⅲ gastric cancer undergoing D2 radical surgery and adjuvant chemotherapy.

    Methods

    Gastric cancer patients who underwent D2 radical surgery and adjuvant chemoradiotherapy were collected from the Department of Radiotherapy at Zhongshan Hospital affiliated to Fudan University from 2009 to 2014. They were pathologically diagnosed with stage Ⅲ gastric cancer according to the International Union of Cancer (UICC) and American Cancer Federation (AJCC) 8th edition TNM staging system for gastric cancer. All postoperative patients were followed up every 3 months in the first year, every 6 months for the following 2 years, and once a year thereafter. The deadline for follow-up is December 15, 2021. Survival rates of subgroups were compared using Log-rank tests.The influencing factors of overall survival (OS) and disease-free survival (DFS) were compared using Cox proportional hazards regression analysis, and the prediction of clinicopathological features were analyzed by Nomogram. Comparison of survival differences among patients with different pTNM stagings, age, metastatic lymph node radios (LNR), and gastrectomy methods using Kaplan-Meier method.

    Results

    A total of 135 qualified patients were included, with a median follow-up time of 10.48 years. Within 5 years, there were 70 cases of recurrence and 62 deaths. The 5-year DFS rate and OS rate were 48.1% (65/135) and 54.1% (73/135), respectively; Within 10 years, there were 74 cases of recurrence and 74 deaths. The 10-year DFS rate nd OS rate were both 45.2% (61/135). The Log-rank test results showed that there was a statistically significant difference in 5-year survival rates among patients with different pTNM stagings, pT stagings, LNRs, cancer nodules, tumor locations, and gastrectomy methods (P<0.05). The 10-year survival rates of patients with different pTNM stagings, pT stagings, LNRs, nerve infiltrations, and gastrectomy methods were compared, and the differences were statistically significant (P<0.05). The results of multivariate Cox proportional hazards regression analysis showed that pTNM staging (Stage ⅢA, OS: HR=0.40, 95%CI=0.19-0.83; DFS: HR=0.40, 95%CI=0.19-0.92), LNR (>50%, OS: HR=1.74, 95%CI=1.03-2.94; DFS: HR=1.73, 95%CI=1.02-2.94), and gastrectomy method (total gastrectomy, OS: HR=2.07, 95%CI=1.22-3.50; DFS: HR=2.02, 95%CI=1.20-3.41) were independent influencing factors for OS and DFS in patients with stageⅢ gastric cancer undergoing D2 radical surgery with adjuvant chemotherapy (P<0.05), while age (≤ 40 years, HR=2.19, 95%CI=1.06-4.53) was an independent influencing factor for OS. Moreover, nomogram indicated that age, pTNM staging, LNR, and gastrectomy method have good predictive effects on the prognosis. For recurrence, 10 cases (7.4%) experienced local recurrence (recurrence of anastomotic sites and lymph nodes within the radiation field), 35 cases (25.9%) experienced abdominal and pelvic dissemination of implants, and 37 cases (27.4%) experienced distant metastasis (including lung, liver, bone, brain and other organs) ; Some patients had two or more types of recurrence. The postoperative survival curves of stageⅢ gastric cancer patients with different pTNM stagings, age, LNRs, and gastrectomy methods were compared, and the differences were statistically significant (P<0.05) .

    Conclusion

    Most patients with stageⅢ gastric cancer who undergo adjuvant chemoradiotherapy after D2 radical surgery experience recurrence or death within 5 years. pTNM staging, LNR, and gastrectomy method are factors that affect the prognosis of these patients.

    Table and Figures | Reference | Related Articles | Metrics
    Interpretation of the Screening Tool of Older Person's Potentially Inappropriate Prescriptions/Screening Tool to Alert to Right Treatment (STOPP/START) Criteria (Version 3)
    ZHU Suyan, ZHENG Xiaomeng, FAN Miao, CHEN Chunyan
    Chinese General Practice    2024, 27 (33): 4097-4104.   DOI: 10.12114/j.issn.1007-9572.2024.0037
    Abstract1206)   HTML38)    PDF(pc) (1214KB)(1007)       Save

    The Screening Tool of Older Person's Potentially Inappropriate Prescriptions (STOPP) and the Screening Tool to Alert to Right Treatment (START) were initially developed by a panel of experts from Cork University Hospital, Ireland in 2008, and underwent a second update in 2015. Since their inception, these criteria have played a pivotal role in identifying potentially inappropriate medication use in the elderly, enhancing oversight of medication misuse in older individuals, and reducing adverse drug events among the elderly. In 2023, the third edition of the STOPP/START criteria was released, providing updated and more practical evidence-based guidance. Building upon the second edition, this iteration includes the addition, revision, and removal of certain criteria, resulting in a total of 190 new standards for potentially inappropriate medication use. This latest version incorporates the most recent research findings and clinical evidence related to appropriate medication use in older adults. We provide a detailed analysis of the STOPP/START criteria (version 3), offering valuable insights for the updating and refinement of potentially inappropriate medication criteria in our country. Furthermore, it presents recommendations for future research in this field.

    Table and Figures | Reference | Related Articles | Metrics
    Clinical Practice Guideline for the Prevention and Treatment of Stroke with Integrated Traditional Chinese and Western Medicine (2023 Edition)
    NI Xiaojia, LIN Hao, LUO Xufei, KUANG Zhuoran, LIU Yunlan, GUO Jianwen, CHEN Yaolong, CAI Yefeng, Working Group of Clinical Practice Guideline for the Prevention and Treatment of Stroke with Integrated Traditional Chinese and Western Medicine
    Chinese General Practice    2025, 28 (05): 521-533.   DOI: 10.12114/j.issn.1007-9572.2024.0485
    Abstract1204)   HTML37)    PDF(pc) (788KB)(1375)       Save
    Recently,the burden of stroke in China is currently increasing,and the clinical evidences have emerged in the field of integrative medicine for stroke. To standardize the prevention and treatment of integrative medicine for stroke,twelve research questions were identified after evaluating the necessity of updating guideline and selecting research questions,which were based on "Evidence-based Practice Guideline on Integrative Medicine for Stroke 2019". The guideline project was set up to China Association of Chinese Medicine as "Clinical Practice Guideline for the Prevention and Treatment of Stroke with Integrated Traditional Chinese and Western Medicin". Eighteen recommendations regarding integrative medicine for ischaemic stroke,haemorrhagic stroke,and complications of stroke were proposed following the latest clinical practice guidelines,systematic retrieval and objective evaluation of clinical evidence,experience of clinical experts of Chinese and Western medicine,discussion in working group,and solicited opinion. This guideline provided scientific and specific guidance for medical practitioners at all levels,and promoted the standardized application of integrative medicine for stroke,to reduce the death,recurrence and disability of stroke.
    Table and Figures | Reference | Related Articles | Metrics
    Traditional Chinese Medicine Policies and Development Status in China
    WAN Xiaowen, HUANG Rong, MA Lirong, SHI Muran, SHENG Wenbin, ZENG Cheng, WU Ning
    Chinese General Practice    2025, 28 (10): 1161-1169.   DOI: 10.12114/j.issn.1007-9572.2024.0267
    Abstract1149)   HTML16)    PDF(pc) (1415KB)(652)       Save

    The research on traditional Chinese medicine policies in China's academic circles became increasingly active and the connotations became richer. However, most of the existing research focused on a certain specific field of traditional Chinese medicine policies, lacking all-round comprehensive research. By systematically retrieving China's traditional Chinese medicine-related policies and journal literature from 2011 to 2023 and obtaining the comprehensive statistical system data of traditional Chinese medicine, this article analyzed Chinese medicine policies from the 12th Five-Year Plan to the 14th Five-Year Plan from the perspectives of Chinese medicine, health care, scientific research, education, industry and culture, reviews relevant Chinese medicine policies and measures, sorts out the development status. It found that China had problems such as insufficient basic Chinese medicine service ability, imperfect Chinese medicine health care network, imperfect education model, and weak scientific research strength. It also proposed to strengthen the traditional Chinese medicine medical system, strengthen health care for treating non-sick patients, strengthen the construction of scientific research forces, integrate and innovate the education model, strengthen the supervision of the traditional Chinese medicine industry, and promote the dissemination of traditional Chinese medicine culture and health education.

    Table and Figures | Reference | Related Articles | Metrics
    Deep Transcranial Magnetic Stimulation Combined with Escitalopram Oxalate in the Treatment of Depression: a Randomized Controlled Trial
    PANG Lan, LI Peifan, ZHU Xiaogang, YANG Zaihong, ZHENG Lei
    Chinese General Practice    2024, 27 (17): 2098-2103.   DOI: 10.12114/j.issn.1007-9572.2023.0555
    Abstract1130)   HTML26)    PDF(pc) (1751KB)(715)       Save
    Background

    Depression is a common psychiatric disorder with limited treatment options. Deep transcranial magnetic stimulation (dTMS), as a new non-invasive neuromodulation technique, has been utilized in the treatment of major depressive disorder (MDD), but there is less evidence from clinical studies.

    Objective

    To explore the clinical efficacy of dTMS combined with escitalopram oxalate (Esc) in the treatment of depression, and provide further reliable data reference for dTMS in the treatment of depression patients.

    Methods

    A total of 73 patients with depression who attended Department of Psychiatry, Affiliated Hospital of Guizhou Medical University from December 2021 to January 2023 were selected as the study subjects and divided into the control group (n=35) and combined treatment group (n=38) according to the random number table. Patients in the control group were given Esc ( 10 mg per day in the first week and 20 mg per day from the second week for 2 consecutive weeks). The combined treatment group received the treatment of dTMS (left DLPFC as the stimulation target, 18 Hz, 120%MT, 1 980 times per day for 2 weeks, 10 times in total) based on the same treatment for the control group. The depressive symptoms and cognitive improvement of patients in the two groups were evaluated before and after the two weeks of treatments by Hamilton depression scale (HAMD), Beck Scale for Suicide Ideation (BSS), Montreal Cognitive Assessment Scale (MoCA) and the mean oxygenated hemoglobin (oxy-Hb) concentration in the prefrontal cortex measured by functional near-infrared spectroscopy (fNIRS) based on the verbal fluency text (VFT) task.

    Results

    The actual completion of the trial was 30 cases in the control group and 31 cases in the combined treatment group. After treatment, the HAMD and BSS scores of the combined treatment group were lower than those of the control group, and the MoCA score was higher than that of the control group (P<0.05). After treatment, the HAMD and BSS scores of patients in the two groups were lower than those before treatment, and the MoCA score was higher than that before treatment (P<0.05). There was no significant activation of the prefrontal cortex after treatment in both groups. The improvement of depression symptoms and cognitive function in the combined treatment group was better than that in the control group.

    Conclusion

    The combination of dTMS and Esc can improve the depressive symptoms and cognitive function better than Esc treatment alone in depression patients.

    Table and Figures | Reference | Related Articles | Metrics
    Coronary Heart Disease Risk Prediction Model Based on Machine Learning
    YUE Haitao, HE Chanchan, CHENG Yuyou, ZHANG Sencheng, WU You, MA Jing
    Chinese General Practice    2025, 28 (04): 499-509.   DOI: 10.12114/j.issn.1007-9572.2023.0323
    Abstract1092)   HTML24)    PDF(pc) (2772KB)(733)       Save
    Background

    Coronary atherosclerotic heart disease (CHD) is one of the leading causes of mortality worldwide, and research on risk assessment for CHD has been growing annually. However, the issue of data imbalance in these studies is often overlooked, despite its crucial role in enhancing the accuracy of CHD risk identification within classification algorithms.

    Objective

    To investigate the factors influencing CHD and to establish predictive models for CHD risk using two data balancing methods based on five algorithms, comparing the predictive value of these models for CHD risk.

    Methods

    Utilizing cross-sectional survey data from the 2021 Behavioral Risk Factor Surveillance System (BRFSS) in the United States, a cohort of 112 606 participants was identified, featuring 24 variables related to risk behaviors and health status, with self-reported coronary heart disease (CHD) as the outcome measure. Factors influencing the incidence of CHD were explored through univariate analysis and stepwise logistic regression to select pertinent variables for inclusion in the predictive model. A random sample comprising 10% of the participants (11 261 individuals) was drawn and then randomly divided into training and testing datasets at an 8∶2 ratio. To address data imbalance, two over-sampling techniques were employed: random oversampling and the Synthetic Minority Over-sampling Technique (SMOTE). Based on these methods, CHD predictive models were constructed using five different algorithms: K-Nearest Neighbors (KNN), Logistic Regression, Support Vector Machine (SVM), Decision Tree, and XGBoost.

    Results

    Univariate analysis revealed significant differences (P<0.05) between the CHD and non-CHD groups across all input variables except for rental housing and being informed of prediabetic status. Stepwise Logistic regression identified age, gender, BMI, ethnicity, education level, income level, being informed of hypertension, being informed of prehypertension, being informed of pregnancy-induced hypertension, current use of antihypertensive medication, being informed of hyperlipidemia, being informed of diabetes, smoking status, alcohol consumption within the last 30 days, heavy drinking status, and self-assessed health as factors influencing CHD. The performance of risk models using SMOTE showed overall classification accuracies of 59.2%, 67.4%, 66.2%, 69.2%, and 85.9%; recall rates of 75.2%, 71.4%, 70.5%, 62.9%, and 34.8%; precision of 15.4%, 18.2%, 17.5%, 17.6%, and 28.7%; F-values of 0.256, 0.290, 0.280, 0.275, and 0.315; and AUC values of 0.80, 0.78, 0.72, 0.72, and 0.82, respectively. Using random oversampling, the models achieved classification accuracies of 62.5%, 68.5%, 69.0%, 60.2%, and 70.1%; recall rates of 70.0%, 69.5%, 71.9%, 69.0%, and 67.6%; precision of 15.8%, 18.4%, 19.1%, 14.8%, and 19.0%; F-values of 0.258, 0.291, 0.302, 0.244, and 0.297; and AUC values of 0.80, 0.77, 0.72, 0.72, and 0.83, respectively.

    Conclusion

    This study not only confirmed known factors affecting CHD but also identified potential impacts of self-assessed health level, income level, and education level on CHD. The performance of the five algorithms was significantly enhanced after employing two data balancing methods. Among them, the XGBoost model exhibited superior performance and can be referenced for future optimization of CHD prediction models. Additionally, considering the excellent performance of the XGBoost model and the convenience and interpretability of stepwise logistic regression, a combined use of these approaches after data balancing is recommended in CHD risk prediction models.

    Table and Figures | Reference | Related Articles | Metrics
    Analysis of the Proportion and Trend of Outpatient Visits for Pediatric Allergic Diseases in Beijing from 2014 to 2021
    HOU Xiaoling, HUANG Huijie, JIANG Nannan, LI Ang, KONG Qin, WEI Mian, XIANG Li
    Chinese General Practice    2024, 27 (27): 3395-3400.   DOI: 10.12114/j.issn.1007-9572.2024.0006
    Abstract1067)   HTML15)    PDF(pc) (1549KB)(172)       Save
    Background

    The prevalence of allergic diseases is rapidly increasing among the global population, affecting 10%-40% of people worldwide. Allergic diseases often begin in childhood. So far, data for analyzing the trends in the incidence of pediatric allergic diseases in China over the past decade are scant. This study aims to provide an epidemiological support for the prevention and management of pediatric allergic diseases in China by mining electronic medical record data from a single-center institution.

    Objective

    To analyze the annual proportion and trend of outpatient visits for allergic diseases among children aged 0-18 years in the Beijing Children's Hospital, Capital Medical University from 2014 to 2021.

    Methods

    A retrospective analysis of outpatient electronic medical records from the hospital information system of Beijing Children's Hospital, Capital Medical University from 2014 to 2021 was conducted to examine the annual proportional composition and changes in the trend changes of allergic diseases. The gender- and age-based proportions of different allergic diseases including eczema, urticaria, allergic rhinitis, bronchial asthma, allergic cough, allergic conjunctivitis, food allergies, drug allergies, pollen allergy, and anaphylaxis were calculated. The trend of changes in the proportion of allergic diseases with stable annual composition ranking in the top 10 was further analyzed.

    Results

    From 2014 to 2021, there were a total of 1 231 890 outpatient visits for pediatric allergic diseases in our center. After excluding missing data, a total of 1 231 863 eligible cases were included, involving 727 082 (59.0%) boys and 504 781 (41.0%) girls. The majority of children visited for allergic diseases were under the age of 3 years (46.9%). Non-IgE mediated allergic diseases, such as henoch-schoenlein purpura, bronchitis, and respiratory tract infections were excluded, and the remaining 1 208 265 cases included in the disease spectrum analysis. From 2016 to 2021, the proportion of outpatient visits for pediatric allergic diseases in Beijing Children's Hospital, Capital Medical University showed an upward trend. From 2014 to 2017, the top 5 allergic diseases visited in the outpatient department were eczema, urticaria, allergic rhinitis, bronchial asthma, and allergic cough. From 2018 to 2021, allergic rhinitis, eczema, urticaria, allergic conjunctivitis, and bronchial asthma ranked the top 5. The trend analysis for an annual proportion of pediatric allergic diseases showed that the ratios of allergic rhinitis, allergic conjunctivitis, and food allergies among all allergic diseases from 2014 to 2021 showed an increasing trend, with peak ratios of 45.4%, 11.1% and 2.8%, respectively. The ratios of urticaria, eczema, and bronchial asthma showed a decreasing trend, with peak ratios of 46.5%, 24.9% and 11.3%, respectively.

    Conclusion

    From 2016 to 2021, the proportion of outpatient visits for pediatric allergic diseases in Beijing Children's Hospital, Capital Medical University showed an upward trend. Between 2014 and 2021, the annual proportions of allergic rhinitis, allergic conjunctivitis, and food allergies exhibited an increasing trend, while the annual proportions of eczema, urticaria, and bronchial asthma demonstrated a decreasing trend.

    Table and Figures | Reference | Related Articles | Metrics
    Investigation and Future Trend Prediction of Disease Burden of Elderly Type 2 Diabetes Mellitus Globally and in China from 1990 to 2021
    ZHAO Xiaoxiao, KE Lixin, XUN Yangqin, WANG Haibo, GAO Wulin, QIAO Tianci, LU Xiaohui, WU Jibiao, LU Cuncun
    Chinese General Practice    2025, 28 (16): 2050-2058.   DOI: 10.12114/j.issn.1007-9572.2024.0497
    Abstract1063)   HTML5)    PDF(pc) (2739KB)(154)       Save
    Background

    Type 2 diabetes mellitus (T2DM) among the elderly has become a significant public health problem both globally and in China, affecting population health. It is extremely urgent to clarify the related disease burden.

    Objective

    To assess the disease burden of T2DM among the elderly population globally and in China from 1990 to 2021, project future trends, and offer insights to inform public health and medical decision-makings.

    Methods

    Data on incidence and mortality burdens of individuals aged 60 years and above with T2DM in China and around the world were extracted from the global Burden of Disease (GBD) 2021 database. Age-standardized incidence and mortality rates were estimated based on the GBD 2021 standard population. Joinpoint regression was utilized to calculate the average annual percentage change (AAPC) for assessing disease burden trends. Subgroup analyses were performed based on age and sex, and decomposition analysis was performed to examine how aging, population growth, and epidemiological changes impacted disease burden. Bayesian models were employed to forecast prevalence and mortality between 2022 and 2035.

    Results

    In 2021, the global incidence of T2DM stood at 6 047 049, while in China, it reached 800 764, representing increases of 178.68% and 220.28%, respectively, compared to the incidence in 1990. Over the period from 1990 to 2021, the global age-standardized incidence rate exhibited a significant overall upward trend (AAPC=1.21%, P<0.001), whereas the trend in China was not statistically significant (AAPC=0.29%, P=0.189). The number of deaths among elderly T2DM patients in 2021 in the global and Chinese populations was 1 304 150 and 149 972, respectively, marking increases of 164.68% and 197.98% compared to the number of deaths in 1990. Throughout the same period, the global age-standardized mortality rate displayed a consistent upward trend (AAPC=0.32%, P<0.001), while the trend in China remained relatively stable (AAPC=0.01%, P=0.922). Notably, the number of incidence and mortality for female in 1990 and 2021, globally and in China, exceeded those of males. Meanwhile, the 60-64 age group had the highest proportion of incidences in 2021, while the 70-74 age group had the highest proportion of deaths. Population growth emerged as the primary influencer driving the rise in incidence and mortality in elderly T2DM patients in both global and Chinese populations, as revealed by decomposition analysis. The projection indicates a continued increase in the incidence and mortality of elderly T2DM patients worldwide and in China from 2022 to 2035.

    Conclusion

    The persistent heavy burden of incidence and mortality among elderly individuals with T2DM in both global and Chinese populations necessitates urgent reinforcement and formulation of more effective public health policies and clinical prevention and control strategies to alleviate the fundamental burden associated with this demographic.

    Table and Figures | Reference | Related Articles | Metrics
    The Design and Application of In-depth Interview in Primary Care Research
    XU Zhijie, WANG Yang, QIAN Yi
    Chinese General Practice    2024, 27 (22): 2797-2806.   DOI: 10.12114/j.issn.1007-9572.2022.0597
    Abstract1049)   HTML36)    PDF(pc) (2176KB)(2933)       Save

    In-depth interview is to understand the life experience and lifestyle of a certain social group through in-depth conversation with the respondents, explore the formation process of specific phenomena, and propose ideas and recommendations to solve problems. In-depth interview has been widely used in the study of primary care research. Thus, understanding its basic concept and mastering the design and application process are essential to master this method. This paper comprehensively describes the research process of in-depth interview research according to the 3 stages at before, during and after the research. Before formally conducting in-depth interview research, researchers need to understand its basic concepts, characteristics and limitations related to the research purpose and process, and identify which studies are applicable. In the design and implementation of in-depth interview research, researchers should focus on the main steps of the research in four stages: recruitment of interviewees, design and modification of interview guide, collection of interview data, and analysis of interview data. After completing the data analysis of the in-depth interview, researchers need to write a research paper referring to the report specification of qualitative research to increase the credibility of research results and the transparency of the research process. In addition, this paper recommends five fields suitable for in-depth interviews in primary care research, and introduces learning resources for researchers to master in-depth interview methods. Through the introduction of in-depth interview research method, this paper aims to help researchers in the field of general practice/primary care to master a method suitable for scientific research, and provide methodology reference for improving the quality of qualitative research in this field in China.

    Table and Figures | Reference | Related Articles | Metrics
    Association of Lipid Accumulation Product Index and Chronic Kidney Disease in Patients with Hypertension with Abnormal Glucose Metabolism: a Retrospective Cohort Study
    ZHANG Xin, ZHU Qing, LI Nanfang
    Chinese General Practice    2025, 28 (15): 1840-1846.   DOI: 10.12114/j.issn.1007-9572.2024.0304
    Abstract1042)   HTML15)    PDF(pc) (1552KB)(81)       Save
    Background

    The incidence and prevalence of chronic kidney disease (CKD) remain high. Hypertension and diabetes frequently coexist and jointly accelerate the progression of kidney disease. The lipid accumulation product index (LAPI) is a novel indicator for predicting cardiovascular disease and abnormalities in glucose metabolism, and its relationship with CKD warrants further investigation.

    Objective

    This study aimed to investigate the relationship between LAPI and the risk of developing CKD in patients with hypertension and abnormal glucose metabolism.

    Methods

    A retrospective cohort of 2 033 patients with hypertension and abnormal glucose metabolism admitted to the Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region from January 2012 to May 2019 was enrolled. General patient information and laboratory test indicators were collected. The LAPI was calculated, and the population was divided into four groups based on LAPI quartiles: Q1 (LAPI≤44.03, n=509), Q2 (44.03<LAPI≤64.68, n=508), Q3 (64.68<LAPI≤98.90, n=508), and Q4 (LAPI>98.90, n=508). Patients were followed up, with the endpoint event being CKD. Kaplan-Meier curves were used to analyze the cumulative incidence of CKD at different LAPI levels, and the Log-rank test was used to compare differences. Multivariate Cox regression models were employed to analyze the relationship between LAPI and CKD. Restricted cubic splines were fitted to the multivariate Cox regression model to explore the dose-response relationship between LAPI and CKD. Subgroup analysis and sensitivity analysis were conducted to test the stability of the relationship between LAPI and CKD.

    Results

    Significant differences were observed in age, gender, BMI, waist circumference, heart rate, diastolic blood pressure, smoking, alcohol consumption, uric acid, total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein, glycated hemoglobin, fasting blood glucose, use of calcium channel blockers, and hypoglycemic treatment among the 4 groups (P<0.05). Log-rank test results indicated that the cumulative risk of CKD increased with elevating LAPI levels (χ2=14.48, P<0.001). Multivariate Cox regression analysis revealed that for each standard deviation increase in LAPI, the hazard ratio (HR) for CKD increased by 12.5% (HR=1.125, 95%CI=1.035-1.223, P=0.005) ; compared to the Q1 group, the Q4 group had a 54.9% higher risk of CKD (HR=1.549, 95%CI=1.129-2.125, P=0.007). Restricted cubic spline regression analysis showed that LAPI>65.59 was a risk factor for CKD (P=0.007). Interaction and subgroup analyses revealed that the association between LAPI and the risk of developing CKD remained stable.

    Conclusion

    In patients with hypertension and abnormal glucose metabolism, a higher LAPI in the early stages increases the risk of developing CKD.

    Table and Figures | Reference | Related Articles | Metrics
    Domestic and International Advances and Challenges in Early Diagnosis of Prediabetes with Integrated Chinese and Western Medicine
    PENG Hongye, JING Yanan, LIU Dianchun, WANG Ying, XUE Xue, LU Chunli
    Chinese General Practice    2025, 28 (03): 262-272.   DOI: 10.12114/j.issn.1007-9572.2024.0328
    Abstract1034)   HTML35)    PDF(pc) (1468KB)(411)       Save

    Prediabetes is a condition characterized by impaired fasting glucose, impaired glucose tolerance, or a combination of both, which is classified under the category of "Pi Dan" in Traditional Chinese Medicine (TCM). With the changes in modern lifestyles, the prevalence of prediabetes is continuously rising, carrying a risk comparable to diabetes prognosis. Therefore, timely diagnosis and early intervention are crucial. This article reviewed the origins and definitions of prediabetes from both TCM and modern medical perspectives, revealing that TCM had already recognized "Pi Dan" as early as the composition of the "SuWen". With the development of evidence-based medicine and the implementation of standardized clinical research, China has gradually established the standardized clinical practice guidelines for prediabetes with TCM characteristics. Regarding diagnosis, diagnostic indicators and thresholds for monitoring blood glucose levels, various non-invasive integrated TCM and modern medical diagnostic methods, including TCM syndrome diagnosis, integrated TCM and Western medicine diagnostic models, disease risk scoring models, biomarkers, and wearable devices, have been continuously improved. However, its primary focus lies in diabetes prevention rather than the early detection and screening of prediabetes. Besides, 1-hour plasma glucose may be a new outcome for prediabetes diagnosis or identifying high-risk diabetes populations in the future. However, further research is required to validate its broader application. Addressing the challenges of dynamic diagnostic standards, complex screening processes, atypical clinical symptoms, and low disease awareness during early prediabetes diagnosis, it is imperative to continuously update and refine diagnostic standards. The integration of digital health management and wearable devices should be promoted to fully capitalize on TCM strengths in constructingt disease diagnostic models that combine TCM macro manifestations and omics microdata for prediabetes. Simplified and expedited integrated TCM and modern medical screening methods can facilitate early screening, early diagnosis, early intervention, and early recovery for prediabetes.

    Table and Figures | Reference | Related Articles | Metrics
    Research Progress on Stigma of Cognitive Disorders
    YUAN Yiqing, CHEN Honglin
    Chinese General Practice    2025, 28 (05): 631-638.   DOI: 10.12114/j.issn.1007-9572.2023.0437
    Abstract1020)   HTML20)    PDF(pc) (1958KB)(1863)       Save

    Cognitive impairment is also known as cognitive disorders. With the rapid aging of the population, the number of people affected by cognitive disorders and the Alzheimer's disease is on the rise. The stigma associated with cognitive disorder is widely recognized in the international community, but related research in this field remains limited. This paper found that definition and measurement of stigma of cognitive disorders need to be standardized, there is a lack of research on economically underdeveloped areas and evidence to establish causal inference; and there is ample room for improvement in both the quantity and quality of intervention studies. The research on stigma of cognitive disorders provides an unique opportunity to break the binary subject perspective in the traditional field of stigma research. At the same time, the discussion on the mechanism of cognitive disorder stigma formation can also deepen the academic discussion on labeling theory and attribution theory.

    Table and Figures | Reference | Related Articles | Metrics
    Effects of Threshold Inspiratory Muscle Training Combined with Continuous Positive Airway Pressure on Sleep and Respiratory Function in Stroke Patients with Obstructive Sleep Apnea-hypopnea Syndrome: a Randomized Controlled Trial
    LIU Yihan, ZHU Ning, XUE Mengzhou
    Chinese General Practice    2024, 27 (17): 2077-2082.   DOI: 10.12114/j.issn.1007-9572.2023.0842
    Abstract1008)   HTML42)    PDF(pc) (1607KB)(229)       Save
    Background

    There is a close association between obstructive sleep apnea-hypopnea syndrome (OSAHS) and stroke. The coexistence of the two diseases not only affects the rehabilitation process of patients, prolongs their hospitalization time, but also may increase the risk of death. At present, there is still a lack of clinical research on continuous positive airway pressure (CPAP) combined with respiratory training for stroke patients with OSAHS.

    Objective

    To examine the impact of threshold inspiratory muscle training (TIMT) in conjunction with CPAP on sleep status, pulmonary function, and respiratory muscle strength in stroke patients with OSAHS.

    Methods

    Sixty-nine patients with stroke and OSAHS who met the enrollment criteria were selected from the Second Affiliated Hospital of Zhengzhou University from April 2022 to August 2023. The patients were divided into experimental group (n=35) and control group (n=34) by random number table method. The control group received CPAP and conventional treatment, and the experimental group received TIMT on this basis for 6 weeks. The sleep status, lung function and respiratory muscle function of the two groups were compared before and after intervention.

    Results

    Six weeks after the intervention, the mean blood oxygen saturation (SpO2), proportion of deep sleep (proportion of N3 sleep in total sleep time), minimum arterial oxygen saturation (LSaO2), forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), one-second rate (FEV1/FVC), maximum expiratory pressure (MEP) and maximum inspiratory pressure (MIP) were all higher than those before intervention in the 2 groups (P<0.05) ; After 6 weeks of intervention, SpO2, proportion of deep sleep (proportion of N3 sleep in total sleep time), LSaO2, FEV1, FVC, FEV1/FVC, MEP and MIP in experimental group were higher than those in control group (P<0.05). Sleep apnea hypopnea index (AHI), oxygen loss index (ODI), arousal index and Epworth lethargy scale (ESS) scores in the 2 groups were lower than those before intervention (P<0.05). After 6 weeks of intervention, the ODI, arousal index and ESS scores of experimental group were lower than those of the control group (P<0.05) .

    Conclusion

    TIMT combined with CPAP can significantly improve the sleep disorder of stroke patients with OSAHS, and improve arterial oxygen partial pressure, respiratory muscle strength and pulmonary function.

    Table and Figures | Reference | Related Articles | Metrics
    Chinese Expert Consensus on Clinical Management of the Psychosomatic Symptoms in Patients with Cancer
    YIN Yingying, ZHAO Kuan, WANG Cailian, TANG Lichen, HE Hongbo, LIU Xiangxin, PAN Yu, YANG Hailong, YANG Yang, ZHOU Bo, XIE Ke, LIN Zheng, YU Linzhen, LUO Yanli, LU Zheng, WANG Xiaoping, REN Tao, ZOU Shaohong, WEI Jing, FENG Wei, YUAN Yonggui
    Chinese General Practice    2025, 28 (15): 1809-1822.   DOI: 10.12114/j.issn.1007-9572.2024.0575
    Abstract992)   HTML55)    PDF(pc) (1419KB)(421)       Save

    Cancer patients are often accompanied by serious psychosomatic symptoms such as depression, anxiety, insomnia and pain, which seriously affect the quality of life and prognosis of patients. However, these symptoms are often under-appreciated and poorly treated. At present, the domestic consensus on the management of cancer lacks the content of psychosomatic symptoms. Therefore, this consensus systematically describes the clinical management methods of psychosomatic symptoms related to cancer patients, combining relevant literature and integrating practical management tools. It comprehensively answers the important questions of physician-patient communication, diagnosis and evaluation, psychological intervention, drug treatment, and how to establish the physician-nurse-patient-family alliance of cancer-related psychosomatic symptoms. Aim at raising awareness of cancer-related psychosomatic symptoms among non-psychiatrists, and selecting effective communication, treatment and management of psychosomatic symptoms with the help of psycho-psychological and other multidisciplinary teams.

    Table and Figures | Reference | Related Articles | Metrics
    Values and Preferences of Pharmacotherapy in Patients with Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease: a Mixed-methods Study
    LI Shenghan, DU Heyue, AN Kang, HE Longtao, LI Jing, LI Sheyu
    Chinese General Practice    2024, 27 (27): 3336-3343.   DOI: 10.12114/j.issn.1007-9572.2024.0056
    Abstract983)   HTML9)    PDF(pc) (1253KB)(180)       Save
    Background

    Pharmacotherapy is the cornerstone of primary and secondary prevention of atherosclerotic cardiovascular diseases (ASCVD), but the values and preferences of community patients for pharmacotherapy remain unclear.

    Objective

    To understand the values and preferences surrounding pharmacotherapy among community patients at risk of or undergoing treatment for ASCVD, which would help clarify the individualized treatment burden and provide patient-centered clinical practice.

    Methods

    This study employed a sequential exploratory mixed-methods design. Firstly, we recruited eligible patients in West China Hospital of Sichuan University and Yulin Community Health Service Center in Wuhou District, Chengdu City from November 2021 to January 2022. for a focus group discussion, aiming to collect qualitative insights into their experience, values, and preferences for medication use. The software MAXQDA 2020 was used to support qualitative data analysis, and Colaizzi's seven-step approach was further used to identify themes. After completing the qualitative phase, a questionnaire was designed based on the emergent themes to further quantitatively analyze the values and preferences regarding pharmacotherapy.

    Results

    Four themes emerged from the qualitative data, including knowledge and use of medications, barriers of medication use, facilitators of medication use, and need for medical services. A total of 186 valid questionnaires were collected in the quantitative study (response rate of 93.5%). The quantitative data showed a commonality in missed dose and confirmed the existence of social stigma and treatment burden in this group of participants. Although preferences in medication use were highly heterogeneous, participants generally preferred taking fewer medications with less frequency, and were less likely to use injectable medications.

    Conclusion

    The study suggests that it may be appropriate to increase the use of compound preparations, and make treatment plans in accordance with patients' daily lives and work to reduce the treatment burden of pharmacotherapy. In addition, we should be active in managing the misconceptions and improper practices in pharmacotherapy in order to improve patients' medication adherence.

    Table and Figures | Reference | Related Articles | Metrics
    Analysis on the Status of 13-Valent Pneumococcal Conjugate Vaccine in Children Born from 2017 to 2022 in Jiangsu Province
    LIU Li, HU Ran, KANG Guodong, ZHANG Lei, WANG Zhiguo
    Chinese General Practice    2025, 28 (15): 1903-1907.   DOI: 10.12114/j.issn.1007-9572.2024.0344
    Abstract959)   HTML4)    PDF(pc) (1700KB)(74)       Save
    Background

    Pneumonia in children poses a serious disease burden globally, and pneumococcal conjugate vaccination is the most direct and effective preventive measure against pneumococcal disease, while there is a lack of information on the coverage of 13-valent pneumococcal conjugate vaccine (PCV13) in children.

    Objective

    To analyze the vaccination rate of PCV13 in children born from 2017 to 2022 in Jiangsu Province, find the difference and reasons under different circumstances, and provide reference on improvement of PCV13 vaccination rate for future.

    Methods

    Through the Jiangsu provincial vaccination management information system, the basic information and vaccination information of PCV13 (as of 2023-12-31) were collected, including the date of birth, gender, household registration attributes, date of vaccination, and the number of doses of vaccination and other basic information, and the data were descriptive analyzed.

    Results

    There were 4 537 123 children registered in the Jiangsu provincial vaccination management information system from 2017 to 2022, of which 784 220 children were vaccinated with 2 406 974 doses of PCV13, with a vaccination rate of 17.28%. In Jiangsu Province, there were 697 698 children given the first dose of vaccination, of which 82 503 (11.83%) were given the first dose at <2 months of age, 511 273 (73.28%) at 2-6 months of age, 26 106 (3.74%) at 7-11 months of age, 38 530 (5.52%) at 12-24 months of age, and 39 286 (5.63%) at 2-5 years of age. The rate of 1, 2, 3, and 4 doses of vaccination was higher among resident children (16.11%, 14.71%, 13.43%, and 11.50%) than among migrant children (13.87%, 12.70%, 11.42%, and 9.52%) (P<0.05). In terms of regional distribution, the vaccination rate of each dose was in the order of South Jiangsu, Central Jiangsu and North Jiangsu from high to low, and the difference was statistically significant (P<0.05). In terms of gender, there was no statistically significant difference in the rates of the first dose and the second doses of vaccination between boys and girls (P>0.05) ; but the rates of the 3rd and 4th doses of vaccination were lower in boys than in girls (P<0.05). Among children born in 2017-2022, the rate of 1, 2, 3, and 4 doses of vaccination increased with the year of birth (P<0.05). The proportion of children aged 2-6 months who received the first dose of PCV13 was the highest among children of different household registration, gender, year of birth and region, and significant differences were also observed in the ages at the first vaccination of the children from various household registration, of both genders, with various regions, and in various years of birth (P<0.05) .

    Conclusion

    The vaccination rate of PCV13 among children in Jiangsu Province is 17.28%, which is at a relatively low level. The age of the first dose of vaccination is the highest in the age of 2-6 months, and the vaccination rate of each dose increases with the year of birth, so in order to improve the coverage level of PCV13 in the target population, it is recommended that PCV13 be included in the National Immunization Program.

    Table and Figures | Reference | Related Articles | Metrics
    Analysis of Disease Burden Trends and Forecast of Alzheimer's Disease and Other Dementias among the Elderly in China from 1992 to 2021
    HAN Shukui, REN Yitao, MA Xin, SONG Panpan, MA Jinxiang, ZHANG Ziyu, CHEN Hongru
    Chinese General Practice    2025, 28 (08): 996-1003.   DOI: 10.12114/j.issn.1007-9572.2024.0519
    Abstract951)   HTML34)    PDF(pc) (2150KB)(217)       Save
    Background

    In the context of an aging society, the number of elderly Alzheimer's disease and related dementia (ADRD) patients in China has been increasing year by year, placing a heavy caregiving burden on their primary family caregivers and garnering extensive attention both domestically and internationally.

    Objective

    This study aims to analyze the burden of ADRD among Chinese elderly individuals, explore the influence of age, period, and cohort factors on its incidence and prevalence, and predict its incidence post-2021, providing a basis for the development of preventive and curative measures by relevant authorities.

    Methods

    Using ADRD data from the Global Burden of Disease Study 2021 (GBD 2021), we extracted the crude incidence rate, crude prevalence rate, crude mortality rate, and crude DALY rate of ADRD among Chinese elderly individuals from 1992 to 2021. After age standardization, we analyzed trends using the Joinpoint regression model and calculated the annual percentage change (APC) and average annual percentage change (AAPC). Age-period-cohort models were used to analyze the effects of age, period, and cohort factors on the incidence and prevalence of ADRD, while Bayesian age-period-cohort models were employed to predict incidence rates from 2022 to 2030.

    Results

    The age-standardized incidence and prevalence of ADRD among China's elderly population from 1992 to 2021 showed an overall increasing trend (incidence: AAPC=0.57%, 95%CI=0.41%-0.72%; prevalence: AAPC=0.64%, 95%CI=0.60%-0.68%). The growth rate of standardized incidence was higher in men than in women (AAPC: 0.63% vs. 0.60%), while the growth in standardized prevalence was higher in women than in men (AAPC: 0.68% vs. 0.66%). The standardized mortality rate decreased across three intervals (1992-2019: APC of -0.11%, -0.41%, and -0.08%) but increased from 2019 to 2021 (APC=1.96%, 95%CI=0.78%-3.15%). The effects of age, period, and cohort factors on ADRD incidence and prevalence were significant. Specifically, the risk of incidence and prevalence increased with age in both men and women over 60 years old, with individuals aged 95 years and older having 13.24 and 13.53 times higher risk of incidence in men and women, respectively, compared to the 60-64 age group. The corresponding prevalence risks were 13.55 and 16.05 times higher. Over time, the risk increased, peaking during 2017-2021. In contrast, cohort effects revealed a progressive decrease in risk with later birth cohorts. By 2030, the standardized incidence rate is projected to increase by approximately 43.62% in women (from 1 267.77 to 1 820.80 per 100 000) and by 36.52% in men (from 920.22 to 1 256.30 per 100 000). Additionally, the number of ADRD cases among men and women was expected to rise significantly, with increases of 89.74% and 105.06%, respectively, between 2021 and 2030.

    Conclusion

    The increasing burden of ADRD in China's elderly population highlights the need for effective measures, particularly to protect elderly women.

    Table and Figures | Reference | Related Articles | Metrics
    Interpretation of the Clinical Statement for Management of Female Cardiac Emergencies in 2024
    HUANG Chuanying, LIAO Xiaoyang, YANG Rong, LI Dongze, ZHANG Peng, JIA Yu, LIU Lidi
    Chinese General Practice    2025, 28 (12): 1427-1432.   DOI: 10.12114/j.issn.1007-9572.2024.0314
    Abstract950)   HTML14)    PDF(pc) (1258KB)(213)       Save

    Cardiac emergencies occur rapidly and pose a serious threat to the health and lives of patients. Female cardiac emergencies have been under-researched, under-diagnosed and under-treated due to gender bias and atypical symptoms for a long time. There are clear gender differences in the pathophysiological mechanisms, risk factors, management and outcomes of female cardiac emergencies. In China, the prevalence of female cardiac emergencies is notably high, and research on it has commenced relatively late. There is no authoritative guideline for female cardiac emergencies, so it is urgent to enhance the management strategies for these conditions. To standardize the management of cardiac emergencies in women and enhance health outcomes, clinicians from general medicine, cardiology and emergency medicine were convened to interpret the clinical statement titled Management of Female Cardiac Emergencies published in 2024 by the Association for Acute Cardiovascular Care and other organizations.

    Table and Figures | Reference | Related Articles | Metrics
    Research Progress in the Study of Traditional Chinese Herbal Medicine Extracts Regulating Ferroptosis thus Improving the Symptom of Alzheimer's Disease
    PEI Jinying, SONG Jinzhou, MA Daofeng, LUO Xiaoting, LIU Bin, DONG Xiaohong, CONG Shuyuan
    Chinese General Practice    2025, 28 (05): 639-648.   DOI: 10.12114/j.issn.1007-9572.2024.0295
    Abstract950)   HTML13)    PDF(pc) (2244KB)(540)       Save

    Alzheimer's disease (AD) is a common neurodegenerative disease in the elderly population. It's typical clinical manifestation is progressive memory impairment. Ferroptosis, rising as a new research direction on AD biological mechanism in recent years, mainly studies on iron-dependent programmed cell death. A large amount of evidence has shown that AD is closely related to ferroptosis in the brain. However, the exact mechanism of the role ferroptosis has played in AD is still unclear. One of the most popular research results indicates that AD might be induced by iron metabolism disorders, lipid peroxidation, and amino acid metabolism, thereby affecting the deposition of iron ions in the brain. So far, some effective chemical components of traditional Chinese herbs as cures of AD have been studied in depth, such as rhodiola rosea, polygala root, ginkgo biloba, poria cocos, etc. These traditional Chinese herbs have shown remarkable effects in the treatment of AD by means of targeting ferroptosis. In this context, this review systematically elaborates on the metabolism of iron in the brain, the characteristics of ferroptosis, and focuses on the metabolic regulation mechanism of ferroptosis. Meanwhile, this review also discusses the connection between ferroptosis and AD. Furthermore, it lists the effective compositions in traditional Chinese herbs that can improve AD by inhibiting ferroptosis, so as to provide reference information for the development and research of ferroptosis inhibitors in the future.

    Table and Figures | Reference | Related Articles | Metrics
    Application of Artificial Intelligence in Nutritional Management of Patients with Inflammatory Bowel Disease: a Scoping Review
    LI Yiting, TU Wenjing, YIN Tingting, MEI Ziqi, ZHANG Sumin, WANG Meng, XU Guihua
    Chinese General Practice    2025, 28 (14): 1709-1716.   DOI: 10.12114/j.issn.1007-9572.2024.0276
    Abstract950)   HTML22)    PDF(pc) (995KB)(384)       Save
    Background

    Diet plays a critical role in the development, progression and prognosis of inflammatory bowel disease (IBD) . Given that specific nutritional guidelines are limited, nutritional management for patients with IBD remains challenging and fraught with uncertainty. Although previous studies have demonstrated that artificial intelligence (AI) shows promising applications in the nutritional management of patients with chronic diseases, research specifically focused on its application in the nutritional management of patients with IBD remains limited.

    Objective

    To conduct a scoping review of studies on AI in nutrition management of patients with IBD.

    Methods

    Following the methodology of scoping reviews, the databases of PubMed, Web of Science, Embase, Cochrane Library, CINAHL, IEEE Xplore, Association for Computing Machinery Digital Library, SinoMed, CNKI, Wanfang Data, and VIP were systematically searched from inception to March 2024 for studies on the application of AI in the nutritional management of patients with IBD. According to the established inclusion and exclusion criteria, two investigators independently screened the literature, and the basic characteristics of the selected studies were extracted.

    Results

    A total of 15 studies were included. The applications of AI in this field include exploring the relationship between diet and IBD, assisting in nutritional assessment, and aiding nutritional interventions. The majority of utilization AI technologies in the included studies are machine learning, with some also employing additional techniques such as natural language processing and deep neural networks.

    Conclusion

    AI is beneficial for exploring healthy dietary patterns for patients with IBD and providing personalized nutritional guidance. However, its application in the field of nutritional management in patients with IBD is still in its infancy. Future efforts should focus on strengthening multidisciplinary collaboration, emphasizing the integration of clinical guidelines, and assessing the effectiveness of AI applications in clinical settings to enhance the rigor and accuracy of the results.

    Table and Figures | Reference | Related Articles | Metrics